Related content

Antitumor and immunomodulatory effects of lowdose 5FU on hepatoma 22 tumorbearing mice

By              

Oncology Letters, Vol. 7, Iss. 4, 2014-01 ,pp. : 1260-1264

Spandidos Publications

Access to resources Recommend Favorite

Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study

By Fariña-Sarasqueta Arantza   Lijnschoten Gesina   Rutten Harm   van den Brule Adriaan  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1167-1171

Springer Publishing Company

Access to resources Recommend Favorite

Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following “suicide” gene therapy in a murine colon carcinoma model

By Alsheikhly Abdul-Razzak   Zweiri Jehad   Walmesley Alice   Watson Alastair   Christmas Stephen  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 946-954

Springer Publishing Company

Access to resources Recommend Favorite

Flt3-L gene therapy enhances immunocytokine-mediated antitumor effects and induces long-term memory

By Neal Zane   Sondel Paul   Bates Mary   Gillies Stephen   Herweijer Hans  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1765-1774

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Study of Eniluracil/5-FU in Combination with Radiation Therapy for Potentially Resectable and/or Unresectable Cancer of the Pancreas and Distal Biliary Tract

By Czito Brian   Hong Timothy   Cohen Darrel   Petros William   Tyler Douglas   Pappas Theodore   Yu Daohai   Lee Catherine   Lockhart Albert   Morse Michael   Fernando Nishan   Hurwitz Herbert  

Cancer Investigation, Vol. 24, Iss. 1, 2006-03 ,pp. : 9-17

Informa Healthcare

Access to resources Recommend Favorite